SCHEMBL1989714

SCHEMBL1989714

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(-c2ccc(OC)cc2)no1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.72
MAPT P10636 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
PPARD Q03181 4/20 0.42
PPARA Q07869 4/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 4/20 0.41
TSHR P16473 3/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 2/20 0.41
MAPK1 P28482 1/20 0.41
HPGD P15428 1/20 0.40
GAA P10253 1/20 0.40
MCHR1 Q99705 1/20 0.39
HTR1A P08908 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
POLB P06746 1/20 0.39
S1PR1 P21453 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1986905 0.90 GHSR (0.58) GHSRL3MBTL1PPARDPPARATSHR
SCHEMBL1990715 0.90 GHSR (0.58) GHSRNPC1L3MBTL1PPARDPPARA
SCHEMBL1991756 0.88 GHSR (0.62) GHSRMAPTL3MBTL1KMT2AALDH1A1
SCHEMBL1994337 0.87 GHSR (0.57) GHSRMAPTNPC1RAB9AL3MBTL1
SCHEMBL1984223 0.84 GHSR (0.52) GHSRMAPTNPC1RAB9AL3MBTL1
SCHEMBL1990385 0.84 GHSR (1.00) GHSRMAPTNPC1RAB9AL3MBTL1
SCHEMBL1992359 0.83 GHSR (0.53) GHSRPPARDPPARAKMT2AALDH1A1
SCHEMBL1991860 0.83 GHSR (0.53) GHSRPPARDPPARAKMT2AALDH1A1
SCHEMBL1991192 0.83 GHSR (0.52) GHSRMAPTNPC1RAB9AKMT2A
SCHEMBL1989604 0.83 GHSR (0.51) GHSRMAPTNPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885MAPT 4236/4885NPC1 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.